Home » News » FDA Safety Information on Drugs & Medical Devices

FDA Safety Information on Drugs & Medical Devices

May 8, 2017Newsgaladmin

Pulse Oximeter Basics
Source: FDA Consumer Health Information Updates Published on 2025-03-26 By FDA
Safe Use of Megadyne Mega 2000 and Mega Soft Patient Return Electrodes - Letter to Health Care Providers
Source: FDA MedWatch Safety Alert Published on 2025-03-26 By FDA
Endotracheal Tube Recall: Smiths Medical Removes Intubation ORAL/NASAL Endotracheal Tubes Due to Smaller Than Expected Tube Diameter That May Cause Underventilation
Source: FDA MedWatch Safety Alert Published on 2025-03-25 By FDA
Early Alert: Aspiration System Issue from Calyxo
Source: FDA MedWatch Safety Alert Published on 2025-03-20 By FDA
Infusion Pump Software Correction: Becton, Dickinson and Company (BD) Issues Correction for BD Alaris Systems Manager and Care Coordination Engine Infusion Adapter Software Due to Risk for Outdated Automated Programming Requests to Load
Source: FDA MedWatch Safety Alert Published on 2025-03-20 By FDA
Update on Alert: Infusion Pump Issue from Baxter Healthcare Corporation
Source: FDA MedWatch Safety Alert Published on 2025-03-20 By FDA
Update on Alert: Atherectomy Catheter System Issue from Bard Peripheral Vascular
Source: FDA MedWatch Safety Alert Published on 2025-03-20 By FDA
Implantable Port Recall: Smiths Medical Removes ProPort Plastic Implantable Ports Due to Manufacturing Error that May Cause Separation
Source: FDA MedWatch Safety Alert Published on 2025-03-19 By FDA
Embolization Device Recall and Correction: Medtronic Removes Unused 027 Compatible Pipeline Vantage Embolization Device with Shield Technology, Updates Use Instructions for 021 Compatible Pipeline Vantage Embolization Devices due to Increased Risk of Incomplete Wall Apposition and Braid Deformation
Source: FDA MedWatch Safety Alert Published on 2025-03-18 By FDA
Disruptions in Availability of Hemodialysis Bloodlines - Letter to Health Care Providers
Source: FDA MedWatch Safety Alert Published on 2025-03-14 By FDA
Dr. Reddy’s Issues a Nationwide Recall of Levetiracetam in 0.75% Sodium Chloride Injection 1,000 mg/100 mL, in the U.S., Due to Mislabeling of Infusion Bag
Source: FDA MedWatch Safety Alert Published on 2025-03-13 By FDA
Immune Globulin Intravenous (IGIV) and Immune Globulin Subcutaneous (IGSC): Voluntary Lot Withdrawals - Due to Increased Reports of Allergic/Hypersensitivity Reactions
Source: FDA MedWatch Safety Alert Published on 2025-03-11 By FDA
Beware of Ultraviolet Wands That Give Off Unsafe Levels of UV Radiation
Source: FDA Consumer Health Information Updates Published on 2025-03-10 By FDA
Smiths Medical Issues Urgent Medical Device Correction Informing Customers of a Potential Issue with Certain Sizes of Intubation ORAL/NASAL Endotracheal Tubes Being Smaller Than Expected
Source: FDA MedWatch Safety Alert Published on 2025-03-10 By FDA
Update on Alert: Solution Set Issue from Baxter Healthcare Corporation
Source: FDA MedWatch Safety Alert Published on 2025-03-05 By FDA

Related Posts

Yaz, Yasmin, Ocella Lawsuits Pile Up

FL Families Claim Damages Similar to Defective Chinese Drywall

Long-Term Reglan Use Linked to Complications

NY Construction Industry Calls For Section 240/241 Reform

New York Radiation Therapy Accidents Result in Death

Pain Pump Lawsuits Stack Up in State and Federal Courts